Recent studies report that the activation of PPARγ inhibited MMP2 production and tumor cell invasion in several types of cancer, indicating that downregulation of MMP2 by PPARγ could represent an anti‐tumorigenic procedure 16, 17. This evidence concerns the gene PPARG and neoplasm.